# Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma

> **NCT02540135** · NA · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- High Grade Malignant Neoplasm
- Glioblastoma Multiforme
- Anaplastic Astrocytoma

## Interventions

- **OTHER:** fluorescein
- **OTHER:** intraoperative MRI

## Key facts

- **NCT ID:** NCT02540135
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03-01
- **Primary completion:** 2018-07-18
- **Final completion:** 2018-07-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The investigators decided not to move forward with this study at this time.
- **Last updated:** 2018-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540135, "Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02540135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*